abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

هذه الصفحة غير متوفرة باللغة العربية وهي معروضة باللغة English

المقال

22 إبريل 2024

الكاتب:
Reuters

Africa: Johnson and Johnson alleged contaminated children cough syrup banned from shelves, incl. co. response

" Contaminated cough syrup in Africa no longer available - WHO" 22 April 2024

A contaminated batch of Benylin Paediatric Syrup is no longer available in the African countries where it was sold, the World Health Organization said on Monday. Earlier this month, Nigeria recalled a batch of the children's cough and allergy medicine after tests found that it contained unacceptable levels of the toxin, diethylene glycol. Five other African countries have also pulled the product from shelves - Kenya, Rwanda, Tanzania, Zimbabwe and South Africa, where the drug was made. The recalled batch of Benylin syrup was made by Johnson & Johnson (JNJ.N) in South Africa in May 2021, although Kenvue (KVUE.N) now owns the brand after a spin-off from J&J last year. J&J has referred requests for comment to Kenvue. In an emailed statement on Friday, Kenvue said it had carried out tests on the batch recalled by Nigeria and had not detected either diethylene or ethylene glycol, but was continuing to work with the authorities. Diethylene glycol can cause acute kidney failure and alongside another related toxin, ethylene glycol, has been linked to the deaths of more than 300 children in Cameroon, Gambia, Indonesia and Uzbekistan since 2022 after being found in medicines made in India and Indonesia. No children have been reported hurt or killed in the latest incident. The WHO, which has warned countries and companies to be vigilant about the ongoing risk of contamination, said on Friday it was "likely" to issue a broader alert about Benylin. However, on Monday the health agency said it no longer had immediate plans to do so after getting more information at the end of the week. "Considering that this batch is no longer on the market in any of the impacted countries and it has been consumed with no apparent reports of adverse effects, we believe that there is no immediate public health risk," a spokesperson said by email.

معلومات الخصوصية

هذا الموقع يستخدم ملفات تعريف الارتباط وتكنولوجيا التخزين الشبكي. يمكنك ضبط خيارات الخصوصية أدناه. تسري التغييرات فورًا.

للمزيد من المعلومات عن استخدامنا للتخزين الشبكي، انظر سياستنا في استخدام البيانات وملفات تعريف الارتباط

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

ملفات تعريف الارتباط التحليلية

ON
OFF

When you access our website we use Google Analytics to collect information on your visit. Accepting this cookie will allow us to understand more details about your journey, and improve how we surface information. All analytics information is anonymous and we do not use it to identify you. Google provides a Google Analytics opt-out add on for all popular browsers.

Promotional cookies

ON
OFF

We share news and updates on business and human rights through third party platforms, including social media and search engines. These cookies help us to understand the performance of these promotions.

خيارات الخصوصية على هذا الموقع

هذا الموقع يستخدم ملفات تعريف الارتباط وتكنولوجيا التخزين الشبكي لتحسين تجربتك لما يتجاوز الخصائص الرئيسية الضرورية.